177 related articles for article (PubMed ID: 19052407)
1. Histamine 2 blocker potentiates the effects of histamine 1 blocker in suppressing histamine-induced wheal.
Dhanya NB; Rai R; Srinivas CR
Indian J Dermatol Venereol Leprol; 2008; 74(5):475-7. PubMed ID: 19052407
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effects of 5 and 10 mg oral desloratadine and levocetirizine on histamine-induced wheal and flare response in healthy volunteers.
Bulca S; Bayramgürler D; Odyakmaz Demirsoy E; Yavuz M; Sikar Aktürk A; Bilen N; Kıran R
J Dermatolog Treat; 2013 Dec; 24(6):473-6. PubMed ID: 23441762
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of levocetirizine, desloratidine and fexofenadine by histamine wheal suppression test.
Dhanya NB; Thasleem Z; Rai R; Srinivas CR
Indian J Dermatol Venereol Leprol; 2008; 74(4):361-3. PubMed ID: 18797058
[TBL] [Abstract][Full Text] [Related]
4. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
5. A double dose of levocetirizine leads to better control of histamine-induced flare, wheal and itch in healthy donors.
Tanizaki H; Nakamizo S; Nakahigashi K; Miyachi Y; Kabashima K
Pharmacology; 2013; 92(1-2):71-4. PubMed ID: 23942038
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine.
Frossard N; Strolin-Benedetti M; Purohit A; Pauli G
Br J Clin Pharmacol; 2008 Feb; 65(2):172-9. PubMed ID: 17953719
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
Kruszewski J; Kłos K; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers.
Devalia JL; De Vos C; Hanotte F; Baltes E
Allergy; 2001 Jan; 56(1):50-7. PubMed ID: 11167352
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the antihistamine effects of olopatadine and levocetirizine during a 24-h period: a double-blind, randomized, cross-over, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
Takeo T; Kasugai C; Tanaka R; Ando T; Ogawa A; Akita Y; Watanabe D
J Dermatol; 2013 Dec; 40(12):987-92. PubMed ID: 24303975
[TBL] [Abstract][Full Text] [Related]
11. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo.
Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK
Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of cetirizine versus cetirizine plus ranitidine in chronic urticaria: Double-blind randomized placebo-controlled study.
Guevara-Gutierrez E; Bonilla-Lopez S; Hernández-Arana S; Tlacuilo-Parra A
J Dermatolog Treat; 2015; 26(6):548-50. PubMed ID: 25886090
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin.
Clough GF; Boutsiouki P; Church MK
Allergy; 2001 Oct; 56(10):985-8. PubMed ID: 11576078
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial.
Sarkar TK; Sil A; Pal S; Ghosh C; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(5):561-568. PubMed ID: 28656910
[TBL] [Abstract][Full Text] [Related]
15. Levocetirizine in 1-2 year old children: pharmacokinetic and pharmacodynamic profile.
Cranswick N; Turzíkova J; Fuchs M; Hulhoven R
Int J Clin Pharmacol Ther; 2005 Apr; 43(4):172-7. PubMed ID: 15966463
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
[TBL] [Abstract][Full Text] [Related]
17. Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.
Staevska M; Gugutkova M; Lazarova C; Kralimarkova T; Dimitrov V; Zuberbier T; Church MK; Popov TA
Br J Dermatol; 2014 Jul; 171(1):148-54. PubMed ID: 24472058
[TBL] [Abstract][Full Text] [Related]
18. The inhibition by levocetirizine and fexofenadine of the histamine-induced wheal and flare response in healthy Caucasian and Japanese volunteers.
Schoepke N; Church MK; Maurer M
Acta Derm Venereol; 2013 May; 93(3):286-93. PubMed ID: 23147964
[TBL] [Abstract][Full Text] [Related]
19. Levocetirizine and Prednisone Are Not Superior to Levocetirizine Alone for the Treatment of Acute Urticaria: A Randomized Double-Blind Clinical Trial.
Barniol C; Dehours E; Mallet J; Houze-Cerfon CH; Lauque D; Charpentier S
Ann Emerg Med; 2018 Jan; 71(1):125-131.e1. PubMed ID: 28476259
[TBL] [Abstract][Full Text] [Related]
20. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers.
Frossard N; Benabdesselam O; Purohit A; Mounedji N; Pauli G
Fundam Clin Pharmacol; 2000; 14(4):409-13. PubMed ID: 11030449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
